Epstein–Barr virus: LMP1 masquerades as an active receptor

This publication has 16 references indexed in Scilit:

• Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
  Oncogene, 1998
• The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
  Proceedings of the National Academy of Sciences, 1997
• Catalysis by a Multiprotein IκB Kinase Complex
  Science, 1997
• Latent membrane protein 1of Epstein-Barr virus mimics a constitutively active receptor molecule
  The EMBO Journal, 1997
• Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κB activation
  Oncogene, 1997
• Localization of the Major NF-κB-activating Site and the Sole TRAF3 Binding Site of LMP-1 Defines Two Distinct Signaling Motifs
  Journal of Biological Chemistry, 1997
• Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors
  Oncogene, 1997
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
  Cell, 1996
• Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.
  Proceedings of the National Academy of Sciences, 1996
• The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
  Cell, 1995